Who is sponsoring NCT04191772?

NCT04191772 is sponsored by Hasselt University.

What drugs are being tested in NCT04191772?

Interventions in NCT04191772: Periodized, home-based running program.

What condition does NCT04191772 study?

NCT04191772 studies Multiple Sclerosis.

Is NCT04191772 still recruiting?

NCT04191772 is currently completed. Last updated 31 August 2021.

Last reviewed 2021-08-31 · How we verify

NCT04191772: EXIMS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact of Training on Sitting Time and Brain Volumes in Multiple Sclerosis.

Completed NA Last updated 31 August 2021

What this trial tests

NA trial testing Periodized, home-based running program in Multiple Sclerosis in 156 participants. Completed in 30 June 2021.

Timeline

15 January 2020

Primary endpoint
30 June 2021

30 June 2021

Quick facts

Lead sponsor	Hasselt University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	156
Start date	15 January 2020
Primary completion	30 June 2021
Estimated completion	30 June 2021
Sites	1 location across Belgium

Drugs / interventions tested

Periodized, home-based running program

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Hasselt University

Who can join

18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study aims to investigate whether persons with Multiple Sclerosis (PwMS) compensate training time with more sedentary time and consequently blunt training effects. The second aim will be to investigate the effect of a structured training program on specific brain volumes and cognitive variables.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The effect of a structured running exercise intervention on non-exercise physical activity and sedentary behaviour in persons with mild Multiple Sclerosis and healthy controls.
Nieste I, Spaas J, Franssen WMA, Asch PV, et al · · 2023 · PMID 40217416 · DOI 10.1186/s44167-023-00037-1
The effect of structured exercise on non-exercise physical activity and sedentary behaviour in persons with mild Multiple Sclerosis and healthy controls
Nieste I, Spaas J, Franssen WM, Asch PV, et al · · 2023 · DOI 10.21203/rs.3.rs-3203061/v1

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Hasselt University trials

Trials by the same sponsor.

NCT07419100 — Sedentary Behaviour, Physical Activity Patterns, and Cardiometabolic Health · NA · not yet recruiting
NCT07505355 — Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in Multiple Sclerosis · recruiting
NCT07081893 — How do Patients, Relatives and Healthcare Professionals View Person-centered Rehabilitation. · not yet recruiting
NCT06785909 — Proprioceptive, Fear-related and Inflammatory Factors in the Persistence of Pregnancy-related Lumbopelvic Pain. · NA · recruiting
NCT07175792 — Accuracy of Motor Performance Perception in Multiple Sclerosis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04191772 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hasselt University
Last refreshed: 31 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04191772.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing